GlassScriptPhysician profile
Lili Ngo
NPI 1922448224
$3,091.56
in general payments reported to CMS, 2019-2025
17 companies · $598 in 2025
The $598 reported for 2025 was more than what 81% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $575 · 2020: $44.78 · 2021: $256 · 2022: $491 · 2023: $564 · 2024: $563 · 2025: $598.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,566 · Entertainment: $159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,565.52 |
| Entertainment | $159.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $439.47 | 2019-2023 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $389.64 | 2019-2021 | |
| Lkc Technologies, INC. | $372.31 | 2023-2025 | |
| Bausch & Lomb Americas INC. | $351.73 | 2023-2025 | Infuse, Multi-Focal |
| Alcon Vision LLC | $277.84 | 2019-2025 | Precision7 |
| Tarsus Pharmaceuticals, INC. | $226.72 | 2024-2025 | Xdemvy |
| Optos, INC. | $159.36 | 2023-2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Genzyme Corporation | $121.95 | 2019 | |
| Sun Pharmaceutical Industries INC. | $119.27 | 2023 | Cequa |
| Glaukos Corporation | $114.47 | 2019-2025 | Idosetr |
| Biotissue Holdings INC. | $108.20 | 2024 | |
| Dompe US, INC. | $99.41 | 2025 | Oxervate |
| Coopervision INC. | $97.02 | 2024 | Misight Contact Lens |
| Carl Zeiss Meditec USA, INC. | $88.04 | 2022 | |
| Oyster Point Pharma, INC. | $80.00 | 2023 | Tyrvaya |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $28.89 | 2019-2022 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lili Ngo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.